Indawo yokunyibilika | >300 °C (lit.) |
Indawo yokubilisa | 209.98°C (uqikelelo olurhabaxa) |
ukuxinana | 1.4421 (uqikelelo olurhabaxa) |
isalathiso se-refractive | 1.4610 (uqikelelo) |
ixesha lokugcina. | 2-8°C |
ukunyibilika | I-Aqueous Acid (Kancinci), i-DMSO (Kancinci, ishushu, i-Sonicated), i-Methanol (Kancinci, |
ifomu | Umgubo weCrystalline |
pka | 9.45(nge-25℃) |
umbala | Mhlophe ukuya kumthubi kancinane |
Ukunyibilika kwamanzi | IYANYIBILIZWA EMANZINI ATSHISHIYO |
Merck | 14,9850 |
I-BRN | 606623 |
Uzinzo: | Izinzile.Ayihambelani ne-oxidizing agents ezinamandla. |
InChIKey | ISAKRJDGNUQOIC-UHFFFAOYSA-N |
CAS Database Reference | 66-22-8(CAS DataBase Reference) |
NIST Chemistry Reference | Uracil(66-22-8) |
EPA Substance Registry System | Uracil (66-22-8) |
Iikhowudi zeNgozi | Xi |
Iingxelo zoKhuseleko | 22-24/25 |
WGK eJamani | 2 |
RTECS | YQ8650000 |
I-TSCA | Ewe |
Ikhowudi ye-HS | 29335990 |
Usebenzisa | Kuphando lwe-biochemical, ukuhlanganiswa kweziyobisi;isetyenziswa njengendawo yokudibanisa amayeza, ikwasetyenziswa kwi-organic synthesis |
Iindlela zokuvelisa | Iveliswa ngokusabela kwe-malate, i-sulfuric acid kunye ne-urea. |
Inkcazo | I-Uracil isiseko se-pyrimidine kunye nenxalenye esisiseko ye-RNA apho ibophelela kwi-adenine ngokusebenzisa iibhondi ze-hydrogen.Iguqulwa ibe yi-nucleoside uridine ngokudityaniswa kwe-ribose moiety, emva koko kwi-nucleotide uridine monophosphate ngokongezwa kweqela le-phosphate. |
Iipropati zeMichiza | Iinaliti zeCrystalline.Inyibilika emanzini ashushu, ammonium hydroxide, kunye nezinye alkali;enganyibilikiyo etywaleni nakwi-ether. |
Usebenzisa | Isiseko senitrojeni kwi-RNA nucleosides. |
Usebenzisa | i-antineoplastic |
Usebenzisa | Kuphando lwe-biochemical. |
Usebenzisa | I-Uracil (i-Lamivudine EP Ukungcola F) sisiseko senitrogen kwi-nucleosides ye-RNA. |